MedTrace Logo

The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery

NCT00122720 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2006-07-07

No results posted yet for this study

Summary

The study is investigating whether randomization to perioperative darbepoetin alfa treatment improves the rehabilitation following surgery for colonic and rectal cancer.

Conditions

Interventions

DRUG

Darbepoetin Alfa

Sponsors & Collaborators

  • Amgen

    collaborator INDUSTRY

  • Herning Hospital

    lead OTHER

Principal Investigators

  • Charlotte B Norager, M.D. · Surgical Research Department, Herning Hospital, Gl. Landevej 61, DK-7400 Herning

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Completion
2006-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00122720 on ClinicalTrials.gov